## COO: The Cooper Companies, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -1.0% below STRENGTH zone (3.0-6.0%); PEG 2.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($77.57)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. The Cooper Companies (COO)'s technical outlook is bright after key golden cross**
- Source: MSN | 20260101T110810 | Bullish | Relevance: 100%
- This article suggests that The Cooper Companies (COO) has a bright technical outlook due to a recent "golden cross" formation. This bullish indicator often signals upward price momentum, making COO a potentially attractive stock for investors interested in technical analysis. The article implies that this technical event could lead to a sustained positive trend for the stock.

**2. What Makes The Cooper Companies (COO) an Investment Bet?**
- Source: Insider Monkey | 20251231T124259 | Somewhat-Bullish | Relevance: 100%
- Diamond Hill Capital's Mid Cap Strategy initiated a position in The Cooper Companies (NASDAQ: COO) during Q3 2025, viewing it as an attractive investment despite current transitory headwinds. The company, a leader in contact lenses and women's health, is expected to benefit from long-term growth in its markets. While Cooper Companies isn't among the top 30 hedge fund picks, 56 hedge funds held positions at the end of Q3, indicating significant institutional interest.

**3. The Cooper Companies, Inc.'s (NASDAQ:COO) Popularity With Investors Is Clear**
- Source: 富途牛牛 | 20260101T150751 | Somewhat-Bullish | Relevance: 100%
- The Cooper Companies, Inc. (NASDAQ:COO) has a high price-to-earnings (P/E) ratio of 42.8x, significantly higher than the US market average. This lofty P/E is attributed to analyst forecasts predicting substantial EPS growth of 30% annually over the next three years, contrasting with recent earnings declines. Investors are seemingly willing to pay a premium for COO's anticipated strong future growth despite past underperformance.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $88 | $72 | +22% |
| 2025-12-08 | Morgan Stanley | $83 | $76 | +9% |
| 2025-12-08 | Goldman Sachs | $71 | $64 | +11% |
| 2025-12-05 | Stifel | $95 | $85 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Neutral |
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |
| 2025-12-08 | Goldman Sachs | main | Sell |
| 2025-12-05 | Stifel | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 10 ($1.30M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (-1.1%)
- Blackrock Inc.: 7.8% (-0.8%)
- Capital World Invest: 5.4% (+25.7%)
- T. Rowe Price Invest: 5.0% (+33.2%)
- State Street Corpora: 4.4% (-0.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 10 raises (avg +14%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.15 elevated, pricing in significant growth expectations. Analyst sentiment positive (10 raises, avg +14%). Insider buying signal ($1.3M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.1B |
| Beta | 1.05 |
| 52W Range | $61.78 - $100.24 |
| Short Interest | 3.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.15 |
| Forward P/E | 16.4 |
| Current P/E | 18.0 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -1.0% (minimal 5-day change). Below STRENGTH zone by 4.0pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.09x) but short-term weakness (below SMA20). RSI neutral at 55. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.03% (CS: 22) | Neutral |
| RSI_14 | 55.3 | Neutral |
| MACD Histogram | -0.41 | Bearish |
| vs SMA20 | 0.995x | Below |
| vs SMA50 | 1.063x | Above |
| vs SMA200 | 1.089x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $81.11
- **Stop Loss:** $77.57 (4.4% risk)
- **Target:** $84.65 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 406
- **Position Value:** $32,930.66
- **Portfolio %:** 32.93%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-03-05 (Est: $1.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.11 | $1.15 | +3.3% |
| 2025Q3 | $1.07 | $1.10 | +3.0% |
| 2025Q2 | $0.93 | $0.96 | +3.3% |
| 2025Q1 | $0.91 | $0.92 | +0.9% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*